Citation: Gt. Schumock et al., PHARMACOECONOMIC ANALYSIS OF STRESS-ULCER PROPHYLAXIS FOR CRITICALLY ILL PATIENTS, PharmacoEconomics, 9(5), 1996, pp. 455-465
Citation: Cm. Helgason et al., INCREASED DOSAGE REQUIREMENT AND DEVELOPMENT OF ASPIRIN RESISTANCE OVER TIME IN PATIENTS WITH PREVIOUS STROKE, Stroke, 25(1), 1994, pp. 267-267
Authors:
MELLORS JW
DUTSCHMAN GE
IM GJ
TRAMONTANO E
WINKLER SR
CHENG YC
Citation: Jw. Mellors et al., INVITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS-1 RESISTANT TO NONNUCLEOSIDE INHIBITORS OF REVERSE-TRANSCRIPTASE, Molecular pharmacology, 41(3), 1992, pp. 446-451